Latest:
Taking the Fast Track to Independence in Oncology
Rahul S. Shinde, DVM, PhD, reflects on his journey to realizing his dreams of operating his own laboratory and serving as a leader in scientific research.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Raju Kucherlapati, PhD
Latest:
Genomics Studies Opening Up Fresh Options for CRC Research
Raju Kucherlapati, PhD, serves as principal investigator
of a Genome Characterization Center
as part of The Cancer Genome Atlas
program, a National Cancer Institute initiative
aimed at defining the copy number changes and structural aberrations present in many different
cancer types.
Ralph Boccia, MD
Latest:
Dr. Boccia on Managing Adverse Events With CAR T-Cell Therapy
Ralph Boccia, MD, an oncologist at the Center for Cancer and Blood Disorders, associate clinical professor at Georgetown University, discusses managing adverse events associated with chimeric antigen receptor T-cell therapy.
ramaswamy
Latest:
Dr. Govindan on the Future of EGFR-Mutant NSCLC
Ramaswamy Govindan, MD, professor, Department of Medicine, Oncology Division, Medical Oncology, Washington University School of Medicine in St. Louis, discusses the future treatment landscape of EGFR-mutant non–small cell lung cancer (NSCLC).
Ramaswamy Govindan, MD
Latest:
Dr. Govindan on the Phase I Results of AMG 510 Evaluated in NSCLC
Ramaswamy Govindan, MD, professor of medicine, Washington University School of Medicine discusses the results of a phase I study looking at safety, tolerability, pharmacokinetics, and efficacy of KRAS G12C inhibitor, AMG 510 in patients with non-small cell lung cancer.